Últimas noticias sobre Dayforce (NYSE:DAY) Bolsa

DAYFORCE INC

Dayforce

Dayforce is a global technology company providing cloud-based human capital management solutions for large businesses looking to manage their payroll, tax, benefits, and talent intelligence. The company primarily services customers in the US with its flagship Dayforce platform but also services customers in select European countries as well as Australia and New Zealand. Dayforce services the Canadian HCM market with its Powerpay platform that specifically targets customers with less than 100 employees. As of fiscal 2024, the Dayforce platform accounted for almost 80% of companywide revenue and had 6,876 clients representing approximately 7.62 million employees.

Dayforce Inc

DAYFORCE INC COM

Day Hagan Smart Sector ETF

Day Hagan Smart Sector Fixed Income ETF

Day Hagan Smart Sector International ETF

Day One Biopharmaceuticals, Inc. - Common Stock

Day One Biopharmaceuticals Inc

DAY TRADEXCHANGE INC by Day TradeXchange, Inc.

Day TradeXchange Inc

DAYBREAK OIL & GAS INC by Daybreak Oil & Gas, Inc.

Daybreak Oil & Gas Inc

DAYTON & MICH RR GTD by Dayton & Michigan Railroad Co.

Dayton & Michigan Railroad Co

DAYTON & MICH RR 8 PR GTD by Dayton & Michigan Railroad Co.

BPMC

Trading Halt: Halt status updated at 8:45:00 AM ET: Quotation Resumption: News and Resumption Times

Morgan Stanley analyst Kristine Liwag maintains Curtiss-Wright (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CW#NYSE">CW</a>) with a Overweight and raises the price target from $405 to $550.

News

Price Target

Analyst Ratings

Morgan Stanley Maintains Overweight on Curtiss-Wright, Raises Price Target to $550

Stock Split

LCID

Lucid Files Preliminary Proxy Statement To Initiate Plan For 1-for-10 Reverse Stock Split

WIIM

NUWE

Nuwellis shares are trading lower after the company announced it has terminated its REVERSE-HF clinical trial to prioritize resources and redirect investment.

INSE

Inspired Entertainment Expands Long-Term Partnership With William Hill To Deliver Comprehensive Upgrade To William Hill's Virtual Sports Offering Across Its UK Retail Estate

OKLO

Oklo shares are trading higher after the company completed the U.S. Nuclear Regulatory Commission's pre-application readiness assessment for Phase 1 of its combined license application for the Aurora Powerhouse.

Stifel analyst Jeffrey Stantial maintains Monarch Casino &amp; Resort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRI#NASDAQ">MCRI</a>) with a Hold and raises the price target from $81 to $92.

MCRI

Stifel Maintains Hold on Monarch Casino & Resort, Raises Price Target to $92

B. Riley Securities analyst Mike Crawford maintains TTM Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTMI#NASDAQ">TTMI</a>) with a Buy and raises the price target from $36 to $50.

TTMI

B. Riley Securities Maintains Buy on TTM Technologies, Raises Price Target to $50

BTCT

BTC Digital Announces Transformative, Strategic Shift To Fully Embrace Ethereum As Core Asset And Operational Foundation; Closes $6M Financing Round, Adds New $1M ETH Position

Truist Securities analyst Matthew Coad maintains Affirm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) with a Buy and raises the price target from $58 to $72.

AFRM

Truist Securities Maintains Buy on Affirm Holdings, Raises Price Target to $72

U.S. stock futures were mostly lower this morning, with the Dow futures falling around 0.2% on Thursday.
Shares of Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) fell sharply in pre-market trading after the company issued third-quarter <a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/07/46447307/abbott-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">adjusted EPS guidance below estimates.</a>
Abbott posted adjusted earnings of $1.26 per share, beating market estimates of $1.25 per share. The company's sales came in at $11.142 billion versus expectations of $11.068 billion.
Abbott Laboratories said it sees third-quarter adjusted EPS of $1.28 to $1.32, versus estimates of $1.34.
Abbott shares dipped 5.1% to $125.02 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul class="wp-block-list">
<li>Nuwellis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) shares dipped 11.2% to $14.16 in pre-market trading.  Nuwellis shares jumped 131% on Wednesday after the company announced it secured a U.S. patent for an extracorporeal blood filtering machine and methods.</li>
<li>Pitanium Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTNM#NASDAQ">PTNM</a>) declined 7.3% to $12.41 in pre-market trading.</li>
<li>Jade Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBIO#NASDAQ">JBIO</a>) fell 7% to $8.20 in pre-market trading.</li>
<li>MP Materials Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>) dipped 7% to $54.37 in pre-market trading after the company announced a $500 million proposed public offering.</li>
<li>Ingredion Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>) shares slipped 6.8% to $126.07 in pre-market trading.</li>
<li>Guess?, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GES#NYSE">GES</a>) declined 5.8% to $12.00 in pre-market trading.</li>
<li>Standard Lithium Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLI#NYSE">SLI</a>) fell 4.8% to $2.55 in pre-market trading.</li>
</ul>
Now Read This:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46439944/jim-cramer-takes-a-pass-on-this-money-losing-utilities-stock">Jim Cramer &#8216;Takes A Pass&#8217; On This Money-Losing Utilities Stock</a></li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Markets

Movers

Trading Ideas

INGR

JBIO

PTNM

Abbott Laboratories Issues Weak Earnings Forecast, Joins MP Materials And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

VERI

Veritone shares are trading higher after the company announced it has achieved "awardable" status with the Department of Defense's P1 solutions marketplace.

Truist Securities analyst Barry Jonas maintains Monarch Casino &amp; Resort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRI#NASDAQ">MCRI</a>) with a Buy and raises the price target from $105 to $120.

Truist Securities Maintains Buy on Monarch Casino & Resort, Raises Price Target to $120

D. Boral Capital analyst Jason Kolbert maintains VolitionRX (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VNRX#AMEX">VNRX</a>) with a Buy and maintains $5 price target.

VNRX

D. Boral Capital Maintains Buy on VolitionRX, Maintains $5 Price Target

BMNR

BitMine Immersion Now Holds ~$1B Of Ethereum, Exceeding Initial $250M PIPE Proceeds By Over 300%

Government

Regulations

Oklo Completes US Nuclear Regulatory Commission's Pre-Application Readiness Assessment For Phase 1 Of Combined License Application For Aurora Powehouse

Oppenheimer analyst Chris Kotowski maintains Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) with a Outperform and lowers the price target from $57 to $55.

Oppenheimer Maintains Outperform on Bank of America, Lowers Price Target to $55

As the global economy navigates a post-pandemic world, investors are keenly observing evolving market dynamics, including shifts in consumer behavior <a href="https://www.benzinga.com/tech">and technological advancements.</a>
On CNBC's &#8220;<a href="https://www.cnbc.com/video/2025/07/16/final-trades-johnson-johnson-ice-and-the-ibit.html">Halftime Report Final Trades</a>,&#8221; Sarat Sethi, managing partner at DCLA, said he is sticking with Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) amid a positive <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46449538/johnson-johnson-raises-fy25-forecast-joins-rigetti-computing-unity-software-brighthouse-fina">earnings report</a>.
On Wednesday, Johnson &amp; Johnson raised its FY2025 earnings guidance. The company reported a second-quarter 2025 adjusted earnings of $2.77 per share, down 1.8% year over year, beating the consensus of $2.68. The pharmaceutical giant reported sales of $23.74 billion, up 5.8% year-over-year and beating the consensus estimate of $22.85 billion.
Stephen Weiss, chief investment officer and managing partner of Short Hills Capital Partners, named iShares Bitcoin Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>) as his final trade.
Don't forget to check out our<a href="https://www.benzinga.com/premarket/"> premarket coverage here</a>
Joseph M. Terranova, senior managing director for Virtus Investment Partners, picked Intercontinental Exchange, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICE#NYSE">ICE</a>) as his final trade.
Lending support to his choice, Piper Sandler analyst Patrick Moley maintained an Overweight rating for Intercontinental Exchange on Tuesday, raising the price target from $180 to $202.
Price Action:
<ul class="wp-block-list">
<li>Johnson &amp; Johnson shares dipped 5.5% to close at $78.86 on Tuesday.</li>
<li>iShares Bitcoin Trust ETF gained 2.5% during the session.</li>
<li>Intercontinental Exchange shares rose 0.6% to close at $180.80 during the session.</li>
</ul>
Check This Out: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46439944/jim-cramer-takes-a-pass-on-this-money-losing-utilities-stock">Jim Cramer &#8216;Takes A Pass&#8217; On This Money-Losing Utilities Stock</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Media

IBIT

Johnson & Johnson, Intercontinental Exchange And Bitcoin ETF On CNBC's 'Final Trades'

D. Boral Capital analyst Jason Kolbert maintains Quince Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNCX#NASDAQ">QNCX</a>) with a Buy and maintains $4 price target.

QNCX

D. Boral Capital Maintains Buy on Quince Therapeutics, Maintains $4 Price Target

DGXX

Digi Power X shares are trading higher after the company announced it has executed a definitive purchase order with Super Micro Computer to supply NVIDIA B200-powered systems.

Press Releases

Dayforce to Announce First Quarter 2025 Financial Results on May 7th and Participate in Upcoming Investor Conferences

General

Dayforce Now Available in the Microsoft Azure Marketplace

Earnings

Dayforce Reports First Quarter 2025 Results¹

Hubexo Selects Dayforce for Workforce Transformation

Rimini Street Launches Rimini Manage™ for Dayforce

Dayforce Empowers Canadian Small and Mid-Sized Businesses with Powerpay by Dayforce

Dayforce offre aux PME canadiennes les moyens de réussir grâce à Powerpay par Dayforce

Dayforce Research: Taming Friction Key to Simplifying Workplace Complexity

Dayforce Unveils Discover 2025: Discover the Work You're Meant to Do

Dayforce to Announce Second Quarter 2025 Financial Results on August 6th and Participate in Upcoming Investor Conferences

Comments

Dayforce

Noticias

Últimas noticias sobre Dayforce (NYSE:DAY) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL